Skip to main content

Day: October 2, 2020

Surge Copper Amends the Terms of Its Recently Announced Financing, While Ootsa Drill Preparations Are Underway

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW.VANCOUVER, British Columbia, Oct. 02, 2020 (GLOBE NEWSWIRE) — Surge Copper Corp. (the “Company” or “Surge Copper”) (TSX-V:SURG) has amended the terms of the financing announced on September 29, 2020. The Company has had very strong individual and institutional investor demand for the financing, including participation by Altius Resources Inc. and 6 other resource focused institutions, and has increased the flow-through component from C$5,454,545 to C$6,000,000. The total interest in the financing was multiples of the total placement size, including the participation of over 50 entities. The new board and advisory members are subscribing to approximately...

Continue reading

Court of Queen’s Bench of Alberta Approves Painted Pony’s Proposed Transaction with Canadian Natural Resources Limited

CALGARY, Alberta, Oct. 02, 2020 (GLOBE NEWSWIRE) — Painted Pony Energy Ltd. (“Painted Pony”) (TSX: PONY) today announces that the Court of Queen’s Bench of Alberta has granted a final order approving the previously announced proposed transaction with Canadian Natural Resources Limited (TSX, NYSE: CNQ) (the “Arrangement”). The Arrangement was approved by more than 88% of shareholders and optionholders (voting together as a single class) who voted at a special meeting of Painted Pony held on October 1, 2020. The Arrangement is still subject to other standard conditions to closing.Additional information regarding the Arrangement is provided in the management information circular of Painted Pony dated August 31, 2020, which is available on the SEDAR website at www.sedar.com under Painted Pony’s profile. Assuming the satisfaction of...

Continue reading

Summit Announces Agreement For a Fundraising of approximately $50 Million

Summit Therapeutics Inc.(“Summit” or the “Company”)Summit Announces Agreement For a Fundraising of approximately $50 MillionCambridge, MA, October 2, 2020 – Summit (NASDAQ: SMMT) today announces that it has entered into a binding agreement with the Company’s Chief Executive Officer and Executive Chairman, Robert W. Duggan, for a fundraising of approximately $50 million (the “Fundraising”) through the issuance and sale in a private placement of shares of common stock to Mr. Duggan.  The transaction provides Summit the ability to place up to 14,970,060 new shares of common stock with Mr. Duggan in exchange for up to $50 million in new investment. The aggregate purchase price will reflect a price of $3.34 per share of common stock. The price per share of the common stock sold in the Fundraising represents the Nasdaq closing price per share...

Continue reading

Seneca Recalls Cinnamon Apple Chips Because of Possible Health Risk

JANESVILLE, Wis., Oct. 02, 2020 (GLOBE NEWSWIRE) — Seneca Snack Company, a Washington Corporation, is announcing a voluntary recall of Seneca Cinnamon Apple Chips and Clancy’s Cinnamon Apple Chips due to possible Salmonella contamination.  Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting in the bloodstream and producing more severe illnesses such as arterial infections, endocarditis and arthritis.This recall is only for specific cinnamon flavor lot codes, no other flavor apple chips are affected. This only affects Clancy’s...

Continue reading

IGNITE Announces Termination of Agreement With Namaste

VAUGHAN, Ontario, Oct. 02, 2020 (GLOBE NEWSWIRE) — IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”), a global consumer packaged goods brand, today announces the mutual termination of an agreement between IGNITE and CannMart Inc., a wholly-owned subsidiary of Namaste Technologies Inc. (“Namaste”), to utilize certain IGNITE trademarks on cannabis-based products. CannMart will continue selling remaining IGNITE inventory through provincial control boards and through its medical channel at Cannmart.com until December 29, 2020 and will no longer act as a distributor for IGNITE in Canada. IGNITE products, to the extent made available by licensed retailers in Saskatchewan, will also continue to be available on Cannmart.com via it’s VendorLink platform.“It has been a pleasure working with Cannmart to...

Continue reading

Resverlogix Confirms Interim Filings on SEDAR

CALGARY, Alberta, Oct. 02, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announces that, further to its September 25, 2020 press release, it today has filed its interim financial statements and related MD&A for the three months ended July 31, 2020 (the “Interim Filings”). These filings can be found at www.sedar.com under the Company’s profile.About ResverlogixResverlogix is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. Apabetalone is the first therapy of its kind to have been granted US FDA Breakthrough Therapy Designation – for a major cardiovascular indication – to help facilitate a time-efficient drug development program including planned clinical trials and plans for expediting...

Continue reading

Western Pacific Trust Company Appoints New Board Chair

VANCOUVER, British Columbia, Oct. 02, 2020 (GLOBE NEWSWIRE) — Western Pacific Trust Company (Trading Symbol “WP”- TSX-VE) is pleased to announce that director Dr. Anthony Liscio has been appointed Chairman of the Board of Directors of the Company effective September 30, 2020.Dr. Liscio takes over from Mr. J. Cowan McKinney, FCPA, as Board Chair. Cowan McKinney stepped down as Board Chair, having served in that capacity for eight years, but remains as a valued independent director of the Company. The Directors thank Mr. McKinney for his years of wise and thoughtful leadership of the Board, and look forward to his continued contribution.Dr. Liscio has been a Director of the Company since October of 2004, and served as President & CEO of Western Pacific from 2008 to 2011.With this appointment, the Board of Directors is composed...

Continue reading

Draganfly’s Portfolio of Transport Canada Approved Drones Now Includes AeroVironment’s Quantix Mapper Hybrid VTOL UAS

Vancouver, BC, Oct. 02, 2020 (GLOBE NEWSWIRE) — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading manufacturer within the commercial Unmanned Aerial Vehicle (“UAV”), Remotely Piloted Aircraft Systems (“RPAS”), and Unmanned Vehicle Systems (“UVS”) sectors, is pleased to announce Transport Canada’s recent acceptance of the Quantix’s safety assurance declaration for flight in advanced operations.Draganfly is the exclusive worldwide commercial distributor of the Quantix Mapper RPAS, which is now the fifth aircraft in Draganfly’s fleet that meets Transport Canada’s safety assurance certification for RPAS advanced flight operations. Acceptance as an approved aircraft for advanced flight operations allows for more flexibility and flights in controlled airspace.This approval...

Continue reading

A-Labs Capital II Corp. Announces Proposed Qualifying Transaction With RDARS Inc.

/NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, British Columbia, Oct. 02, 2020 (GLOBE NEWSWIRE) — A-Labs Capital II Corp. (the “Company”) (TSX-V: ALAB.P) is pleased to announce that it has entered into a letter of intent (the “LOI”) dated October 1, 2020 with RDARS Inc. (“RDARS”). Pursuant to the LOI, the Company and RDARS have agreed to a proposed acquisition (the “Transaction”) by the Company of 100% of the issued and outstanding securities of RDARS in exchange for the issuance of securities of the Company. The Transaction is intended to constitute the Company’s Qualifying Transaction under Policy 2.4 – Capital Pool Companies of the TSXV Venture Exchange (the “Exchange”).About RDARSRDARS is a private corporation incorporated under the laws of the province of Ontario. Its primary...

Continue reading

Zomedica Announces Name Change

ANN ARBOR, Mich., Oct. 02, 2020 (GLOBE NEWSWIRE) — Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostic products for companion animals, announced that it has changed its legal name to Zomedica Corp. The Company’s stock trading symbol will remain as ZOM on the NYSE American and the shares will begin trading under the new name effective on October 5, 2020.The Company’s board of directors approved the implementation of the name change following approval from the shareholders at the Annual General and Special Virtual-Only Meeting of shareholders held on September 25, 2020.No action will be required by existing shareholders with respect to the name change. As a result of the name change, the Company’s common share CUSIP...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.